Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Johnson and Johnson
Cipla
Fuji
Medtronic
Boehringer Ingelheim
McKinsey
Chinese Patent Office
Accenture
Covington

Generated: October 22, 2017

DrugPatentWatch Database Preview

Betamethasone valerate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for betamethasone valerate and what is the scope of betamethasone valerate patent protection?

Betamethasone valerate
is the generic ingredient in eight branded drugs marketed by Taro Pharm, Schering, Mylan Pharms Inc, Perrigo Uk Finco, Roaco, Taro, G And W Labs Inc, Riconpharma Llc, Actavis Mid Atlantic, Sti Pharma Llc, Perrigo New York, Pharmaderm, Fougera Pharms Inc, Savage Labs, Teva Pharms, and Pharmafair, and is included in thirty-one NDAs. There is one patent protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Betamethasone valerate has twenty-seven patent family members in twenty countries.

There are sixty-six drug master file entries for betamethasone valerate. Twenty suppliers are listed for this compound. There is one tentative approval for this compound.

Summary for Generic Name: betamethasone valerate

US Patents:1
Tradenames:8
Applicants:16
NDAs:31
Drug Master File Entries: see list66
Suppliers / Packagers: see list20
Bulk Api Vendors: see list28
Clinical Trials: see list146
Patent Applications: see list4,842
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:betamethasone valerate at DailyMed

Pharmacology for Ingredient: betamethasone valerate

Tentative approvals for BETAMETHASONE VALERATE

Applicant Application No. Strength Dosage Form
u► Subscribe0.12%FOAM;TOPICAL
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmafair
BETAMETHASONE VALERATE
betamethasone valerate
OINTMENT;TOPICAL070486-001May 29, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe
Teva Pharms
BETAMETHASONE VALERATE
betamethasone valerate
LOTION;TOPICAL071883-001Apr 22, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe
Riconpharma Llc
BETAMETHASONE VALERATE
betamethasone valerate
AEROSOL, FOAM;TOPICAL207144-001May 24, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Mylan Pharms Inc
LUXIQ
betamethasone valerate
AEROSOL, FOAM;TOPICAL020934-001Feb 28, 1999ABRXYesYes► Subscribe► SubscribeY ► Subscribe
Savage Labs
BETATREX
betamethasone valerate
OINTMENT;TOPICAL018863-001Aug 31, 1983DISCNNoNo► Subscribe► Subscribe► Subscribe
G And W Labs Inc
BETA-VAL
betamethasone valerate
CREAM;TOPICAL018642-001Mar 24, 1983ABRXNoNo► Subscribe► Subscribe► Subscribe
Pharmaderm
BETAMETHASONE VALERATE
betamethasone valerate
LOTION;TOPICAL018870-001Aug 31, 1983DISCNNoNo► Subscribe► Subscribe► Subscribe
Fougera Pharms Inc
BETAMETHASONE VALERATE
betamethasone valerate
LOTION;TOPICAL018866-001Aug 31, 1983ABRXYesYes► Subscribe► Subscribe► Subscribe
Schering
VALISONE
betamethasone valerate
CREAM;TOPICAL016322-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Schering
VALISONE
betamethasone valerate
OINTMENT;TOPICAL016740-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: betamethasone valerate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Mylan Pharms Inc
LUXIQ
betamethasone valerate
AEROSOL, FOAM;TOPICAL020934-001Feb 28, 1999► Subscribe► Subscribe
Mylan Pharms Inc
LUXIQ
betamethasone valerate
AEROSOL, FOAM;TOPICAL020934-001Feb 28, 1999► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Generic Ingredient: betamethasone valerate

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,126,920 Method of treating a skin disease with a corticosteroid-containing pharmaceutical composition► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: betamethasone valerate

Country Document Number Estimated Expiration
Slovakia119097► Subscribe
Denmark0813413► Subscribe
Hungary228890► Subscribe
Canada2214436► Subscribe
Poland322088► Subscribe
South Korea100427492► Subscribe
Spain2210349► Subscribe
Czech Republic285913► Subscribe
JapanH11501045► Subscribe
Poland183730► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Novartis
McKesson
Moodys
Deloitte
Baxter
Cerilliant
Dow
Citi
Federal Trade Commission
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot